Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555682 · ClinicalTrials.gov registry record · NA
2-HOBA: Multiple Dosing Study in Healthy Humans
A NA study, sponsored by Metabolic Technologies.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03555682 is a NA study that has completed, run by Metabolic Technologies. The registered enrollment target is 18 participants.
The verdict
NCT03555682, a NA study, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to test how well people tolerate a new dietary ingredient called 2-HOBA and how it is metabolized in the body. 2-HOBA is a compound that occurs naturally in buckwheat seeds. This dietary ingredient has been used in animal studies, and single doses have been tolerated well when given to a small group of healthy people. In this study we will test how well people tolerate taking 2-HOBA over 2 weeks and how it is metabolized by the body.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 2-HOBA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2019-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03555682
The ClinicalTrials.gov registry entry for NCT03555682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metabolic Technologies, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03555682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03555682 about?
NCT03555682 is a clinical study titled "2-HOBA: Multiple Dosing Study in Healthy Humans". The purpose of this study is to test how well people tolerate a new dietary ingredient called 2-HOBA and how it is metabolized in the body. 2-HOBA is a compound that occurs naturally in buckwheat seeds. This dietary ingredient has been used in animal studies, and single doses have been tolerated wel...
What is the current status of trial NCT03555682?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-05-23. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT03555682?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 2-HOBA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03555682?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.